Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Schering
ULTRAVIST SCHEDULING STATUS: S2 PROPRIETARY NAME (and dosage form): ULTRAVIST ULTRAVIST 300 20 mL ULTRAVIST 300 50 mL ULTRAVIST 300 75 mL ULTRAVIST 300 100 mL ULTRAVIST 300 200 mL ULTRAVIST 370 50 mL ULTRAVIST 370 100 mL ULTRAVIST 370 200 mL Non-ionic contrast medium COMPOSITION Ultravist 300 1 mL contains 0,623 g iopromide (5-methoxyacetylamino-2,4,6-triiodisophthalic acid-(2,3-dihydroxy-N-methylpropyl)- (2,3-dihydroxypropyl)-diamide), in aqueous solution. Ultravist 370 1 mL contains 0,769 g iopromide in aqueous solution. Ultravist 300 Ultravist 370 Iodine concentration (mg/mL) 300 370 Iodine content (g) per vial of 20 mL 6,0 - bottle of 50 mL 15,0 18,5 bottle of 75 mL 22,5 - bottle of 100 mL 30,0 37,0 bottle of 200 mL 60,0 74,0 Contrast medium concentration (mg/mL) 623 69 Contrast medium content (g) per vial of 20 mL 12,5 - bottle of 50 mL 31,2 38,4 bottle of 75 mL 46,8 - bottle of 100 mL 62,3 76,9 bottle of 200 mL 124,6 153,8 Viscosity (mPa.s or cP) at 20°C 8,7 20,1 at 20°C 8,7 20,1 at 37°C 4,6 9,5 Osmotic pressure at 37°C (MPa) 1,59 Read the complete document